Pseudouridine
CAT NO.：NC00529 | CAS No.: 1445-07-4 | Purity:
97%
Quality Control:
* Storage：
Store long-term in a tightly closed container,in a cool and dry place.
* Our products are for research use only.
* All descriptions are for reference only,please take the CAS number as the standard.
Product Details
| Synonyms | β-Pseudouridine;5-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | ||
|---|---|---|---|
| CAS | 1445-07-4 | Molecular Weight | 244.20 |
| Catalog Number | NC00529 | MDL | MFCD00038458 |
| Appearance | Off-white to white solid | Melting point | |
| Purity | 97% | Boiling Point | 598.4°C at 760 mmHg |
| Molecular Formula | C9H12N2O6 | Flash Point | |
Safety
| GHS Pictograms |
|
||
| Signal Word | Warning | Class | |
| Precautionary Statements | H302-H315-H319-H335 | UN Number | |
| Hazard Statements | P261-P305+P351+P338 | Packing Group | |
Description
KO-539 is a novel, once-daily, oral investigational drug candidate targeting the menin-KMT2A/MLL protein-protein interaction for treatment of genetically defined AML patients with high unmet need; In preclinical models, KO-539 inhibits the KMT2A/MLL protein complex and has downstream effects on HOXA9/MEIS1 expression. KO-539 has received Orphan Drug Designation from the U.S. Food and Drug Administration for the treatment of AML.
Related Products
| CAS No. | 2140-72-9 |
| Catalog Number | NC00723 |
| Purity | 97% |
| CAS No. | 2140-76-3 |
| Catalog Number | NC00722 |
| Purity | 97% |
| CAS No. | 120595-72-4 |
| Catalog Number | NC00721 |
| Purity |
| CAS No. | 2140-71-8 |
| Catalog Number | NC00720 |
| Purity | 97% |
Historical Records
| CAS No. | 1445-07-4 |
| Catalog Number | NC00529 |
| Purity | 97% |
